Ever wondered what a day in Market Access really feels like? It’s the constant dance between urgent requests, imperfect evidence, and the realities of European reimbursement systems that rarely match corporate ambitions. One moment you're justifying a premium price; the next, you're piecing together models from single-arm studies, hoping they hold up in HTA-driven markets. Along the way, you try to connect payer value with hospital incentives, even when the pieces don’t quite align. Without early, cross-functional strategic thinking, Market Access becomes reactive instead of by design. Read more in our Partner's Blog.